Physician profile
Jeffrey Travis
NPI 1174571533
$5,277.84
in general payments reported to CMS, 2019-2025
41 companies · $1,518 in 2025
The $1,518 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $759 · 2020: $849 · 2021: $97.45 · 2022: $631 · 2023: $506 · 2024: $917 · 2025: $1,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,941.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,110.26 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| W. L. Gore & Associates, INC. | $551.02 | 2020 | |
| Edwards Lifesciences Corporation | $405.63 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Abiomed | $379.65 | 2023-2025 | Impella |
| Angiodynamics, INC. | $196.33 | 2020-2025 | Angiovac |
| Intuitive Surgical, INC. | $181.80 | 2019-2025 | |
| Baxter Healthcare | $158.36 | 2019-2025 | Preveleak |
| Clearflow INC. | $134.57 | 2019 | |
| Lemaitre Vascular, INC. | $120.60 | 2022-2023 | Artegraft Vascular Graft |
| Medtronic, INC. | $82.63 | 2021-2025 | Ligasure, Corevalve Evolut R, Avalus |
| Boston Scientific Corporation | $74.22 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.85 | 2019-2023 | Lifevest |
| Abbott Laboratories | $57.06 | 2023 | Navitor |
| Alnylam Pharmaceuticals INC. | $48.47 | 2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $43.77 | 2019-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $42.71 | 2023-2024 | Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cardiac Non-Synergraft |
| Peerless Surgical INC. | $42.18 | 2024 | |
| La Jolla Pharmaceutical Company | $39.22 | 2022-2025 | Giapreza |
| Ethicon US, LLC | $39.00 | 2022-2024 | Surgicel Nu-Knit, Dermabond Prineo, Vistaseal |
| Conmed Corporation | $38.46 | 2019 | |
| Becton, Dickinson and Company | $38.46 | 2019 | |
| On Target Laboratories, INC | $37.70 | 2025 | Cytalux |
| Kci USA, INC. | $32.65 | 2019-2022 | |
| Bolton Medical INC | $32.32 | 2022 | |
| Amgen INC. | $31.53 | 2019 | |
| Mallinckrodt Enterprises LLC | $28.93 | 2019 | |
| Getinge USA Sales, LLC | $27.70 | 2024 | Cardiohelp |
| Medtronic Vascular, INC. | $26.03 | 2019-2020 | |
| Integra Lifesciences Corporation | $25.59 | 2020 | |
| Bard Access Systems, INC. | $22.07 | 2019 | |
| Terumo Cardiovascular Systems Corporation | $19.44 | 2019 | |
| Portola Pharmaceuticals, LLC | $18.96 | 2019 | |
| Livanova USA, INC. | $16.67 | 2019 | |
| Ambu INC. | $15.84 | 2025 | |
| Chiesi USA, INC. | $15.55 | 2019 | |
| Biom'Up France Sas | $13.10 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.44 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.30 | 2019 | |
| Grifols USA, LLC | $12.04 | 2019 | |
| Molnlycke Health Care US, LLC | $10.73 | 2020 | |
| Biomerieux INC | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Travis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.